Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 01, 2021

SELL
$212.27 - $248.7 $35,024 - $41,035
-165 Reduced 12.62%
1,142 $243,000
Q2 2021

Jul 12, 2021

BUY
$233.58 - $259.14 $20,555 - $22,804
88 Added 7.22%
1,307 $319,000
Q1 2021

Apr 06, 2021

BUY
$221.91 - $258.6 $270,508 - $315,233
1,219 New
1,219 $303,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capital Investment Services Of America, Inc. Portfolio

Follow Capital Investment Services Of America, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Services Of America, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Services Of America, Inc. with notifications on news.